FR1479M - Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine. - Google Patents

Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.

Info

Publication number
FR1479M
FR1479M FR868237A FR868237A FR1479M FR 1479 M FR1479 M FR 1479M FR 868237 A FR868237 A FR 868237A FR 868237 A FR868237 A FR 868237A FR 1479 M FR1479 M FR 1479M
Authority
FR
France
Prior art keywords
biotinate
hydroxocobalamin
healing
drug based
anemic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR868237A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROLLAND LAB A
Laboratoires Albert Rolland SA
Original Assignee
ROLLAND LAB A
Laboratoires Albert Rolland SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROLLAND LAB A, Laboratoires Albert Rolland SA filed Critical ROLLAND LAB A
Priority to FR868237A priority Critical patent/FR1479M/fr
Application granted granted Critical
Publication of FR1479M publication Critical patent/FR1479M/fr
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FR868237A 1961-07-18 1961-07-18 Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine. Active FR1479M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR868237A FR1479M (fr) 1961-07-18 1961-07-18 Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR868237A FR1479M (fr) 1961-07-18 1961-07-18 Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.

Publications (1)

Publication Number Publication Date
FR1479M true FR1479M (fr) 1962-09-10

Family

ID=87764982

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868237A Active FR1479M (fr) 1961-07-18 1961-07-18 Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.

Country Status (1)

Country Link
FR (1) FR1479M (fr)

Similar Documents

Publication Publication Date Title
FR2227M (fr) Médicament anticoagulant a base d'heparine.
FR1916M (fr) Médicament a base de 16.α-méthyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
FR1038M (fr) Médicament a base d'aspirine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR3702M (fr) Médicament a base d'anguidine et de ses dérivés.
FR1704M (fr) Médicament anti-allergique et anti-histaminique a base de β-alanine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR1479M (fr) Médicament cicatrisant et antianémique a base de biotinate d'hydroxocobalamine.
FR2288M (fr) Médicament analgésique et anti-émétique, a base de 1-phényl-3-(beta-diéthylamino-éthyl)-imidazolidones-(2).
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR3139M (fr) 1-halogénophényl-2-amino-alcanones-(1) secondaires et tertiaires a propriétés thérapeutiques.
FR1432M (fr) Médicament détoxicant et antianémique a base de nicotinate d'hydroxocobalamine.
FR1478M (fr) Médicament reconstituant et antianémique a base de panthoténate d'hydroxocobalamine.
FR2231M (fr) Médicament a base de nouvelles dibenzothiéphinnes.
FR2410M (fr) Médicament a base de dérivé de l'oxazine.
BE614059A (fr) Dispositif de coupe et d'emboutissage.
FR1477M (fr) Médicament antianémique a base de folate d'hydroxocobalamine.
FR1987M (fr) Médicament antilipémique a base d'héparine modifiée.
FR2555M (fr) Médicament a base de substance antibiotique.
FR2415M (fr) Médicament a base d'éthanolamines substituées.
FR2860M (fr) Médicament antiviral a base d'interféron.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2577M (fr) Médicament a base de naphtyl-amino-imidazoline.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.